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Abstract
 Incidental findings of virus-like particles were identified followingBackground:
electron microscopy of tissue-engineered tendon constructs (TETC) derived
from equine tenocytes. We set out to determine the nature of these particles, as
there are few studies which identify virus in tendons  , and their presenceper se
could have implications for tissue-engineering using allogenic grafts.
 Virus particles were identified in electron microscopy of TETCs.Methods:
Virion morphology was used to initially hypothesise the virus identity.  Next
generation sequencing was implemented to identify the virus. A pan
herpesvirus PCR was used to validate the RNASeq findings using an
independent platform. Histological analysis and biochemical analysis was
undertaken on the TETCs.
Morphological features suggested the virus to be either a retrovirus orResults: 
herpesvirus. Subsequent next generation sequencing mapped reads to Equid
herpesvirus 2 (EHV2). Histological examination and biochemical testing for
collagen content revealed no significant differences between virally affected
TETCs and non-affected TETCs. An independent set of equine superficial
digital flexor tendon tissue (n=10) examined using designed primers for specific
EHV2 contigs identified at sequencing were negative. These data suggest that
EHV is resident in some equine tendon.
 EHV2 was demonstrated in equine tenocytes for the first time;Conclusions:
likely from   infection. The presence of EHV2 could have implications toin vivo
both tissue-engineering and tendinopathy.
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          Amendments from Version 1
The authors have taken the reviewers’ comments on board and 
adjusted the manuscript to include clarification of the statistical 
analysis, analysis relating to latency associated transcripts and 
discussion regarding other potential reasons for the identification 
of EHV-2 in equine tenocytes.
See referee reports
REVISED
Introduction
Tendons transfer force from muscle to bone, in addition to play-
ing a key role in positioning and reducing locomotion expenditure, 
such as in the equine superficial digital flexor tendon (SDFT). Their 
structure is hierarchical1, with the predominating component being 
a collagen-dominated extracellular matrix (ECM)2. Sparsely distrib-
uted fibroblasts (tenocytes) produce ECM. Tenocytes are utilised 
in the production of tissue-engineered tendon constructs (TETCs), 
which are used within tendon research as a model for in vivo 
tendons, and have been explored as a potential therapeutic modality 
for tendinopathy3.
There are few causes of musculoskeletal disease which have been 
attributed to viral infection, with no previous literature citing viral 
causes of tendinopathy in the horse. Previous viruses implicated 
in tendinopathy of other species include adenovirus and reovi-
rus in tenosynovitis of broiler hens4. This study in broiler hens 
suggests that a primary viral infection coupled with subsequent 
bacterial infection leads to catastrophic musculoskeletal infection 
and death.
Next generation sequencing (NGS) is frequently used as a research 
tool to characterise the transcriptome of eukaryotes, providing 
superior profiling to previously used methods such as microarrays. 
Wang et al.5 describe NGS as a high throughput, highly sensitive 
method for transcriptome analysis. We have previously used it to 
characterise transcriptome-wide gene expression in numerous 
studies, including tendon ageing and disease6. Additionally, it has 
infrequently been used to identify viral isolates within tissues7 with 
a high sensitivity.
In this study equine TETCs were produced to report changing 
protein profiles with ageing. Following electron microscopy, two 
samples were found to contain virus-like structures. The aim of 
this study was to identify these particles using NGS and investigate 
their functional consequences on TETCs.
Materials and methods
All reagents were supplied by Sigma unless otherwise stated.
Sample collection
Equine SDFT was collected from young (n=7; age: 5 years ± 
1.095 SD) and old (n=6; age: 18.5 years ± 2.429SD) donors from 
the equine hospital and abattoir as a by-product of the agricultural 
industry. The Animal (Scientific Procedures) Act 1986, Schedule 
2 does not define abattoir collection as a scientific procedure and 
hence ethical approval was not required. Samples collected from an 
equine hospital were subject to the University of Liverpool ethical 
approval and consent (VREC462).
Tissue-engineered tendon production
Tenocytes were digested from equine SDFT using standard 
collagenase protocol8. Constructs were engineered as previously 
described by Kharaz et al.9. In brief, tenocytes were seeded at 
600,000 cells per well then scored every other day until full con-
traction of the construct. Constructs were harvested at 28 days and 
either snap frozen, collected for standard histology or transmission 
electron microscopy (TEM).
Transmission electron microscopy
TEM of tendon constructs was performed following fixation 
in 2.5% glutaraldehyde in 0.1M sodium cacodylate buffer for 
8 hours, followed by buffer washing procedures and second fixation 
and contrast stain with 0.1% osmium tetroxide for 90 minutes. 
Samples were stained with 8% uranyl acetate in 0.69% maleic 
acid for 90 minutes, dehydrated in ascending ethanol concen-
trations and embedded in epoxy resin. Ultrathin cross-sections 
(60–90 nm) were cut with a Reichert-Jung Ultracut on an ultra-
microtome (Leica Microsystems, Wetzlar, Germany) using a 
diamond knife. Sections were then mounted on 200 mesh copper 
grids and stained with ‘Reynold’s Lead citrate’ stain for 4 minutes. 
Images were viewed in Philips EM208S Transmission Electron 
Microscope (Philips UK Limited, Guildford, UK) at 80K.
Virion investigation
On examination of TEM images, two TETCs were identified 
as containing virus-like particles (V: Y1, Y6). These particles 
were morphologically assessed for virion identification. Particle 
diameter was estimated from electron micrograph images. Particle 
morphological characteristics were observed for virion diame-
ter, presence of a viral envelope, nucleocapsid shape and surface 
projection presence. The number of full capsids, nucleocapsids and 
empty capsids were counted in 22–26 TEM images from each of 
the infected donors. For each sample, resin sections were mounted 
onto copper grids and viewed in the TEM at X 44000 magnifica-
tion. 25–30 successive grid squares were viewed and the first area 
in each grid square which was found to contain virus was photo-
graphed. The images were loaded into ImageJ (version 1.51n)10 
and counts made of virus with: 
i) envelope + nucleocapsid + DNA (full)
ii) envelope + nucleocapsid – DNA (nucleocapsid only),
iii) envelope only (empty).
TEM images were compared to current literature in order to 
provide a morphological reference (Supplementary File 1).
Histological analysis
TETCs were fixed in 4% paraformaldehyde and paraffin embedded. 
Sections were cut at 4µm onto polylysine slides and subsequently 
stained with haematoxylin and eosin (H&E) and Masson’s 
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Trichrome. Histology was assessed using a scoring system 
developed in an unpublished report by Charters11, and shown in 
Supplementary  File 2.
NGS analysis
Two samples of TETCs were submitted for RNASeq, one virally 
affected (V: Y1) and one control (NV). RNA was extracted from 
constructs as previously described, and NGS was performed in 
accordance with the method described by Peffers et al.6. Analysis 
was undertaken by the Centre for Genomic Research, University 
of Liverpool. One µg of total RNA was ribosome depleted with 
the RiboZero Magnetic kit (Illumina, San Diego, California, United 
States). NGS libraries were prepared using the ScriptSeq v2 NGS 
Library Preparation Kit (Illumina, San Diego, California, United 
States). All of the enriched material was used as input material and 
following 15 cycles of amplification, libraries were purified using 
AMPure XP beads. Each library was quantified using Qubit and 
the size distribution assessed using the Agilent 2100 Bioanalyser 
(Agilent, Santa Clara, CA, USA). Libraries were pooled in equi-
molar amounts and quantity and quality of each pool assessed by 
using Bioanalyzer (Agilent, Santa Clara, CA, USA) and subse-
quently by qPCR using the Illumina Library Quantification Kit 
from Kapa (KK4854) on a Roche Light Cycler LC480II accord-
ing to manufacturer’s instructions. The template DNA was loaded at 
300 pM. The sequencing was carried out on one lane of an Illumina 
HiSeq4000 at 2×150 bp paired-end sequencing with v1 chemistry.
Initial processing and quality assessment was undertaken as previ-
ously described12. Coverage plots were created using R. Initially 
a reference sequence file was created using known herpesvirus 
genomes. Reads were then aligned to the reference sequence files 
using Bowtie2 global alignment. PCR and optical duplicate reads 
were subsequently removed using Picard. Resulting alignment files 
were then used as input to Bedtools, (version 2.16.2) which was 
used to calculate coverage across the genomes. The coverage data 
output of this was used as input for a custom R script. Once the 
reads were mapped the number of reads mapped to each transcript 
was undertaken. These counts were calculated using HTSeq-count 
(version 0.6.1p1)13, accepting only hits of quality 10+, and exclud-
ing ambiguous hits and hits on the opposite strand.
NGS analysis: Transcript assembly and removal of host 
genomic reads
Illumina sequence reads were adapter- and quality-trimmed using 
Cutadapt version 1.2.1 (Martin, 2011) and Sickle version 1.200. 
Host sequences were removed by aligning trimmed reads to the 
Equus caballus genome (Equus caballus; EquCab2.56.pep) with 
HiSat (version 2.0.3b)14.
NGS analysis: Viral sequence determination
To taxonomically assign contigs, a BLASTN (MegaBlast, version 
2.2.7+)15) search of the assembled transcripts against the NT data-
base from NCBI was carried out and full taxa information (species, 
order, phylum, superkingdom) was derived based on the best hit, 
using the NCBI taxonomy database (ftp://ftp.ncbi.nlm.nih.gov/
pub/taxonomy/taxdump.tar.gz). The search was carried out with an 
e-value cut off of 1e-5. The results were filtered to identify all hits 
to the virus superkingdom.
All raw read data produced in this study has been submitted to the 
EBI ENA, primary accession PRJEB20552, secondary accession 
ERP022713.
Hydroxyproline assay
Freeze-dried samples (V (n=2) and NV (n=5) of TETC derived 
from the young donors were hydrolysed overnight at 60°C using 
papain reagent. Digests were stored at -20°C and subsequently 
assayed for collagen content by hydroxyproline assay16.
Statistical analysis
Data for the hydroxyproline assay were normality tested prior to 
statistical analysis. Data was considered statistically significant at 
P≤0.05. All normality testing and statistical analysis was undertaken 
using Excel (2010, Microsoft, Redmond, WA, USA) and GraphPad 
prism (2016, version 7, GraphPad Software Inc, CA, USA).
Pan herpesvirus PCR
As RNAseq is not definitive, we used a pan-herpes PCR to confirm 
that the virus in question was indeed a herpes virus and there were 
no other herpesviruses present.
In order to validate the RNASeq findings with a different platform, 
a pan-herpesvirus PCR was undertaken. Samples V; Y1 and Y6 
(virally affected) and a negative control (O3) were tested using a 
pan-herpesvirus PCR using a modified methodology described by 
Ehlers et al.17. This protocol uses dI-substituted primers that offer 
improved sensitivity and specificity than previous protocols18.
Modifications of the components included using 12.5ul of 2x 
Qiagen multiplex PCR master mix containing HotStar Taq DNA 
polymerase (Qiagen, Crawley, UK). The list of primers used in 
pan herpesvirus PCR is available in Supplementary File 3.
Specific EHV-2 PCR assay of equine SDFT
In order to determine the presence of EHV-2 in SDFT of a larger 
equine population, PCR primers were designed to amplify a region 
within a 37kb contig demonstrating an excellent depth of coverage 
(mean 4919x coverage) and 99% homology to EHV-2. The primer 
sequence was; V1 forward GGGCGGAGAATGTAGAGACG, 
V1 reverse GGTGGACTTTAACGGGGAGG (product size 443). 
DNA was extracted from 10 (mean ±SD age: 12.8±7.1) grossly 
normal equine SDFT collected from an abattoir. A QIAmp DNA 
extraction kit (Qiagen, Crawley, UK) following the manufacturer’s 
protocol was used. A sample of EHV-2 positive DNA (kindly 
gifted by Microbiology Diagnostic Laboratory, Institute of 
Veterinary Science, Liverpool) was used as a positive control.
PCR was performed in a final volume of 50ul consisting of 12.5ul 
ThermoPrime 2x ReddyMix PCR Master Mix, 1.5ul forward 
primer, 1.5ul reverse primer, 24.5ul water and 10ul extracted DNA 
template. Following an initial denaturation at 94°C for 9 min, 
products were amplified by 5 cycles of denaturation at 94°C for 
1 min, annealing at 60°C for 1 min and elongation at 72°C for 1 
minute. This was immediately followed by 30 cycles of denatura-
tion at 94°C for 1 min, annealing at 55°C for one min and elonga-
tion at 72°C for one minute. Amplification was followed by a final 
extension at 72°C for 7 min. 15µl of product was electrophoresed 
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on a 1.5% 1× Tris-acetate-EDTA agarose gel containing 10ul of 
PeqGreen. TrackIT 1Kb Plus DNA ladder was used as the standard.
Phylogeny
All phylogenetic analysis was carried out within MEGA (version 
5). DNA sequences were aligned using Clustal W (EMBL-EBI, 
Hinxton, UK). Neighbour-joining trees constructed. Bootstrap 
analysis (1,000 replicates) was used to provide support for indi-
vidual nodes.
Results
Transmission electron microscopy
Two out of 13 samples contained virus-like particles. The virus-like 
particles identified were approximately 100–150nm in diameter, 
and had an indistinct outer border with surface protrusions and 
a cylindrical nucleocapsid (Figure 1A and 1B). Viral particles 
were identified both intracellularly (T) (including intranuclearly) 
and within the extracellular matrix (Figure 1A). A further char-
acteristic present in several of the images observed were ‘empty 
capsids’ within cells (Figure 1C and 1D). Viral families have 
distinct morphological characteristics relating to size, nucleocap-
sid shape, and envelope present, which were used to tentatively 
identity the particles. The virus particles identified within the 
TETCs exhibited a spherical shape, with a visible envelope, 
contained within an icosahedral capsid shape. Virion diameter 
was calculated and was suggestive of a retrovirus or herpesvirus. 
The apparent spiked edge of the viral particles was suggestive of 
a retrovirus. In order to tentatively assess the level of infection 
within the TETCs, the number of tenocytes affected with virus 
particles was counted by examining the TEM images of all the 
donors. Whilst no virus particles were evident in images of the ten 
non-infected donors, 65.4% and 100% of the tenocytes of the two 
infected samples contained virus particles. The number of empty, 
full and nucleocapsids was determined for a set of images from 
both of the virus-infected samples. Results are shown in Table 1.
Histological scoring
There were no significant differences in histological score between 
V and NV based upon the characteristics measured (Figure 2).
Hydroxyproline assay
Contrasting V and NV TETCs showed that there was no significant 
difference in collagen content (Figure 3).
NGS analysis
NGS analysis: Transcript assembly and removal of host genomic 
reads. Illumina sequence reads were adapter- and quality-trimmed 
using Cutadapt version 1.2.1 (Martin, 2011) and Sickle version 
1.200. A summary of raw and trimmed sequence data is shown 
in Supplementary File 4, following host sequence removal, and 
subsequent filtering of mapped reads. Resulting paired-end reads 
were assembled using Trinity version r2013_08_1419 for both 
samples. V resulted in 913,443 transcripts (including isoforms) and 
NV resulted in 788,076 transcripts (including isoforms).
Figure 1. A and B: Electron micrographs of virus-like particles found within TETCs. Tenocyte (T), extracellular matrix viral particles (black 
arrows). C and D: Electron micrographs showing full capsids, nucleocapsids (NC) and empty capsids (white arrows) within both of the TETCs 
from which virus were isolated (C; Y1, D; Y6). Scale bars are shown.
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Figure 2. Histograms of histological scoring of TETCs. Histological scoring of TETCs from virally affected (n=2) and normal (n=8) donors. 
Graphs A–F represent the mean scores + standard deviation of the following characteristics; mean extracellular matrix organisation (A), cell 
shape (B), cellular distribution (C), cellular alignment (D), TETC cellularity (E) and mean total score (F). Where error bars are not present, 
scores for all donors were equal. Further details of the scoring system are available in Supplementary File 2. No significant differences were 
found between virally affected and normal donors (p≤0.05).
Table 1. Counting of full, empty and nucleocapsids in 
virus-infected TETC samples.
Sample Y1 Sample Y6
Sum Mean SD Sum Mean SD
Full capsid 164 7.5 4.5 316 12.2 8.3
Nucleocapsid 
only 129 5.9 5.1 183 7.0 5.3
Full capsid + 
nucleocapsid 293 13.3 5.5 499 19.2 10.6
Empty capsid 261 11.9 20.6 438 16.8 18.8
Empty + 
nucleocapsid 390 17.7 24.3 621 23.9 23.3
SD; standard deviation
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Figure 3. Histogram of collagen content of young TETCs containing virus (V; n=2) and not containing virus (NV; n=5). Graphs represent 
mean± standard error mean of percentage collagen normalised to dry weight. No significant difference was found in collagen content 
(p≤0.05).
NGS analysis: Viral sequence determination. Y6 had 131 
transcripts that hit viral sequences, 129 were assigned to Equid 
herpesvirus 2, a single read was assigned Equine Infectious 
Anaemia (EIA) virus and a single read to Bovine viral diarrhea 
virus (BVDV). For Y6 84.25% reads were mapped to the Equus 
caballus genome and 1.32% to Equid herpesvirus 2 strain G9/92 
complete genome (accession; KM924294.1); the strain that most 
reads mapped to in this sample. Identified gene transcripts are in 
Table 2.
NGS analysis: Latency associated transcripts. Two different types 
of mapping were undertaken in an attempt to identify latency 
associated transcripts. Firstly a megablast run against the entire nt 
database to get taxonomic information, and  secondly a blastx run 
against a database  created of all know ERV genes in animals from 
NCBI (these sequences only appeared for human in NCBI). We 
assessed the two sequences in NCBI that result from a search for 
‘latency associated transcript and herpes’ and ran a blastx for both 
samples against these. Neither resulted in any significant hits.
O3 had 7 transcripts aligned to virus sequences, all assigned Equid 
herpesvirus 2. A further BLASTN20 search against all animal ERV 
sequences from the NCBI database was carried out to check that the 
contigs suggested to be herpesvirus were not ERVs. No significant 
hits to known ERVS were found for contigs assigned as EHV2 in 
the previous search.
NGS: Genome coverage plots of discovered viral sequence 
against EHV2. Coverage plots of the samples were checked 
against the following genomes; Bovine herpesvirus type 1.1 
(AJ004801.1,), Equid herpesvirus 1 strain T953 (KM593996.1), 
Equid herpesvirus 2 strain G9/92 (KM924294.1), Equid herpes-
virus 3 strain AR/2007/C3A (NC_024771.1), Equid herpesvirus 
4 (NC_001844.1), Equid herpesvirus 5 strain 2–141/67 (NC_
026421.1). From these plots for samples NV (O3) (Figure 4a) 
and V (Y6) (Figure 4b), it is clear that the virus isolated from 
TETC Y6 is likely EHV2. There does not appear to be any EHV2 
in the NV sample. Occasional coverage spikes were due to map-
ping low complexity reads which would map well against many 
genomes.
The coverage plot shows that the genomic coverage of the 
TETC virus of EHV2 strain G9/92 was 86.26%. The virus was 
mapped to 3,875.605 contigs to EHV-2, compared with 2–339 from 
the rest of the herpesvirus panel (EHV1, 3, 4, 5).
Pan herpesvirus PCR. Pan herpesvirus PCR was found to be 
positive for EHV2 for the two V samples and negative for NV 
samples (Figure 5). Sequencing of PCR products was used to 
confirm EHV2 presence within the sample.
Specific PCR. Of the ten samples assessed, none were found to 
contain EHV2 (Figure 6).
Phylogenic analysis. A phylogenetic tree was produced in order 
to characterise the relationship between the TETC virus and 
currently identified EHVs (Figure 7). Phylogenetic analysis of the 
TETC isolated virus glycoprotein B gene shows branching with 
Equid herpesvirus 2 strain 275, with further close relationships with 
strains G9/92, 86/87 and 86. The phylogenetic tree produced clearly 
demonstrates that the strain isolated from the TETCs is an EHV2, 
although not a strain which currently has been genome sequenced 
in the NCBI database.
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Table 2. The reads mapping to specific genes/transcripts 
in EHV2 (G9/92). Counts are presented in the table calculated 
using HTSeq-count.
Read 
Count
Gene 
Name Product
0 E1 membrane protein E1
0 E10 apoptosis regulator E10
286 E2 protein E2
86 E3 membrane protein E3
867 E4 apoptosis regulator BALF1
34 E5A protein E5A
3018 E6 membrane protein BILF1
0 E6A protein E6A
853 E6C protein E6C
260 E7 interleukin-10
1704 E7A envelope glycoprotein 42
777 E8 apoptosis regulator E8
8 E9 membrane protein E9
4275 ORF10 protein G10
6163 ORF11 virion protein G11
5187 ORF17 capsid maturation protease
0 ORF17.5 capsid scaffold protein
2661 ORF18 protein UL79
6867 ORF19 DNA packaging tegument protein UL25
3165 ORF20 nuclear protein UL24
2484 ORF21 thymidine kinase
697 ORF22 envelope glycoprotein H
5154 ORF23 tegument protein UL88
13490 ORF24 protein UL87
3629 ORF25 major capsid protein
721 ORF26 capsid triplex subunit 2
736 ORF27 envelope glycoprotein 48
157 ORF28 envelope glycoprotein 150
21228 ORF29 DNA packaging terminase subunit 1
4507 ORF3 protein G3
9 ORF30 protein UL91
286 ORF31 protein UL92
971 ORF32 DNA packaging tegument protein UL17
1339 ORF33 tegument protein UL16
1194 ORF34 protein UL95
107 ORF35 tegument protein UL14
833 ORF36 tegument serine/threonine protein kinase
1325 ORF37 deoxyribonuclease
Read 
Count
Gene 
Name Product
737 ORF38 myristylated tegument protein
2950 ORF39 envelope glycoprotein M
3897 ORF40 helicase-primase subunit
1333 ORF42 tegument protein UL7
2535 ORF43 capsid portal protein
5864 ORF44 helicase-primase helicase subunit
782 ORF45 tegument protein G45
492 ORF46 uracil-DNA glycosylase
26 ORF47 envelope glycoprotein L
1296 ORF48 tegument protein G48
861 ORF49 protein G49
5403 ORF50 protein Rta
538 ORF51 envelope glycoprotein 350
376 ORF52 virion protein G52
579 ORF53 envelope glycoprotein N
2793 ORF54 deoxyuridine triphosphatase
756 ORF55 tegument protein UL51
5083 ORF56 helicase-primase primase subunit
1693 ORF57 multifunctional expression regulator
935 ORF58 envelope protein UL43
1058 ORF59 DNA polymerase processivity subunit
3208 ORF6 single-stranded DNA-binding protein
990 ORF60 ribonucleotide reductase subunit 2
1362 ORF61 ribonucleotide reductase subunit 1
954 ORF62 capsid triplex subunit 1
4884 ORF63 tegument protein UL37
13692 ORF64 large tegument protein
1382 ORF65 small capsid protein
1095 ORF66 protein UL49
597 ORF67 nuclear egress membrane protein
292 ORF67A DNA packaging protein UL33
1494 ORF68 DNA packaging protein UL32
1249 ORF69 nuclear egress lamina protein
1356 ORF7 DNA packaging terminase subunit 2
1328 ORF70 thymidylate synthase
3639 ORF73 nuclear antigen LANA-1
5 ORF74 membrane protein G74
3677 ORF75 tegument protein G75
1561 ORF8 envelope glycoprotein B
2966 ORF9 DNA polymerase catalytic subunit
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Figure 4. A and B. Log2-Coverage plot demonstrating read mapping. A. Read mapping plot of NV (O3). B. Read mapping plot of V (Y6). Both 
samples were mapped against the Equid herpesvirus 2 strain G9/92 (KM924294) genomes. Y-axes; coverage is log2-scaled. Zero coverage 
bases were assigned a log2-coverage value of -3 for plotting purposes.
Figure 5. Pan herpesvirus gel image. Gel image of PCR fragments following restriction by ECOR 1. Virus-infected samples Y1, Y6 and 
virus negative sample O3 are shown. Amplicon size is 229 bp. Bands were removed and subsequently sequenced to confirm identification 
of herpes virus.
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Figure  6. EHV2 PCR assay  in  an  additional  cohort  of SDFT samples. DNA extractions from ten equine SDFT samples (1–10) were 
amplified with primers (V1) designed within a EHV-2 contig identified following NGS. Genomic DNA from EHV-2 was used as a PCR positive 
control (EHV) and water as a negative control (bl). TrackIT 1Kb Plus DNA ladder was used as a marker (1kb ladder). The positive EHV2 
control demonstrates a band at 450bp.
Discussion
This study is the first to identify EHV2 within cells derived from 
equine tendons. Findings of virus particles in samples of TETCs 
in which TEM was undertaken were incidental. At the time in our 
laboratory, equine tenocytes were the only cell type being cultured. 
We were interested in the nature of the particles and thus set out 
to investigate further. As this was a post-experiment attendant 
result identified a number of weeks after the end of the study, we 
were unable to undertake culture of the virus-infected tenocytes or 
determine what the titre of the virus was and if this was infectious. 
We realise this is a limitation of our work. However, as the pres-
ence of EHV2 was previously unreported in tendons, and due to the 
potential use of TETCs as allogenic transplant agents, we believe 
the finding of EHV2 in tenocytes could have implications for 
future tissue-engineering studies. Additionally, it should serve as a 
warning that viral contamination of musculoskeletal tissues may 
not be appreciated if screening is not undertaken.
Initial analysis tentatively identified a herpesvirus through 
electron microscopy, and this was confirmed as EHV2 with NGS 
and a pan-herpesvirus PCR. The structure of virion particles on 
TEM was initially suggestive of a retrovirus or a herpesvirus. 
Differential features based upon morphology included glycopro-
tein spikes, suggestive of a retrovirus21, and undefined tegument 
protein, suggestive of a herpesvirus22. We demonstrated the 
presence of empty capsid structures within both TETCs. Previous 
studies have hypothesised that empty capsids are precursors of 
mature herpesvirus23,24. Previous images identifying A-capsids24 are 
similar to those in our study, further implicating identification of 
an equid herpes virus. This, coupled with measurement of virion 
Figure 7. Neighbour-joining trees. Trees characterised the relationship between virus isolated from V (EHV2 RJW248419) and previously 
isolated strains using glycoprotein B gene. Bootstrap analysis (1,000 replicates) was used to provide support for individual nodes.
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diameter, was suggestive of a herpes or retrovirus25. Due to the 
non-conclusive ultrastructural features in regard to differentiating 
between a herpesvirus and retrovirus, further analytical methods 
were employed to distinguish viral identity.
NGS identified the virus within the TETCs as most similar to 
EHV2 strain G9/92. Phylogenic analysis of the sequence isolated 
through NGS (EHV2 RJW 248419) demonstrated the close 
relationship between the virus in this study and the currently 
sequenced strains.
Swenson et al.26 studied the presence of feline herpesvirus-1 
(FHV1) within the feline tendon following experimental inocu-
lation. It has previously been described that tissue-engineered 
tendons can be used as allographic transplant agents27. They 
implied that the presence of FHV1 for application of TETCs in 
allogenic transplantation could lead to immune rejection of the 
engineered tissue and hence transplant failure. Whilst the histologi-
cal structure and collagen content of the TETCs was not altered by 
the presence of EHV2, the ability of EHV2 within TETCs here to 
survive culture and multiple passages whilst retaining the ability 
to reproduce, may have implications for their use as a therapeutic 
option in terms of transplant rejection.
In the literature, isolation of primary virus within tenocytes is 
limited, though fibroblasts from other anatomical locations have 
demonstrated the ability for viral replication. Klevjer-Anderson 
et al.28 describe the persistent infection of equine dermal fibroblasts 
with EIA. Further virus isolated from fibroblasts include herpes 
simplex virus within avian fibroblast cells. Stulberg et al.29 dis-
cuss the growth of herpes simplex virus within cultured fibrob-
lasts, illustrating a cytopathic effect upon cells cultured using a 
non-plasma technique. Such areas of focal necrosis were not 
evident in the TETCs here.
Viral causes of tenosynovitis have previously been described in 
chickens4. The study investigated outbreaks of tenosynovitis in 
commercial broilers using virus isolation. Tendon from affected 
flocks yielded isolation of reoviruses and adenoviruses. To our 
knowledge, viral agents have not previously been isolated from 
tendons in horses. Zeng et al.30 used TEM to visualise adenovirus 
particles. Their TEM images suggest that adenoviruses are much 
smaller than the particles isolated in this experiment, with the 
approximate diameter being 70–90nm. A similar result was evident 
with reoviruses’, which have an average diameter of 60–80mm.
Whilst all culturing was undertaken in sterile conditions the iden-
tified virions could have originated from a culture contaminant. 
Likely causes include cross-contamination between TETCs and 
other tissue within the laboratory or use of contaminated reagents 
during production. Previous studies have found viral contamina-
tion in commercially available foetal calf serum such as that used 
in TETC production here. However, as the virus was limited to a 
subset of cultured TETC this is unlikely. Viral isolates include 
BVDV, bovine parainfluenza virus-3 and bovine herpesvirus-1 
(BoHV1)31,32. Membrane filtration removes many contaminants, 
however these may be an ineffective against viruses due to their 
small size33.
It is important to consider host-range and tissue specificity of 
viruses, which could be present as a contaminant of tissue cul-
ture reagents. Foetal calf serum was used in the tissue-engineered 
culture system. As a result, we compared the viral reads obtained 
to a variety of bovine virus’ with suggestive morphology. One read 
to BoHV1 was identified in virally affected TETC. As an alpha-
herpesvirus BoHV1 has previously shown limited scope for cross-
ing species-barriers34. The single read to BoHV1 when compared 
with EHV2 (129) suggest that BoHV-1 was not the virus isolated 
here. Moreover, the BoHV1 read could be a consequence of cross 
mapping. One read was found to EIA. This is a notifiable disease 
within the UK. The single read was of only 52bp hence it was 
suspected due to cross-mapping and further investigation was not 
pursued.
One additional potential explanation for the presence of EHV-2 
in the samples is the ubiquitous nature of EHV-2 in both foals  to 
adult horses35.  One might predict that it is not surprising to identify 
EHV-2 in tendon but perhaps more surprising that it was identi-
fied in only two of 13 samples. A number of studies have described 
equine gammaherpesviruses such as EHV-2 in peripheral blood 
mononuclear cells (PBMCs)36. EHV-2 is latent in B lymphocytes 
and direct cell to cell contact between epithelial cells and B lym-
phocytes is required for the production of infection37.  In a study 
of Icelandic horses of EHV-2 in PBMCs and a selection of tissues 
using a co-cultivation technique 80% of horses examined dem-
onstrated infectious replicating virus38. These studies suggest 
that EHV-2 or cells containing the viral genes could have been present 
in a high proportion of tendon taken. Whilst every effort was made 
to remove tendon from the lower limbs during dissection in a aseptic 
manner cross contamination by other infected or latently-infected 
cells cannot be ruled out. Thus it is possible the tendon derived 
EHV-2 came from cell to cell contact of either PBMC or other donor 
cells and that this was the route of infection. However of the two 
infected samples (both from young donors) one was from the 
abattoir collection and one from the equine hospital. It would 
have been expected that more than one abattoir sample would be 
affected if this was the case as these were harvested, handled and 
processed at the same time. 
Whilst the PCR for EHV-2 on tendon did not find any viral 
DNA this test cannot confirm lack of presence of latency asso-
ciated transcript RNA. We did not identify the presence of 
latency associated transcripts in the RNAseq data. When the two 
sequences in NCBI that result from a search for ‘latency associated 
transcript and herpes’ were used neither resulted in any significant 
hits.  Thus whilst latency associated transcripts cannot be ruled 
out with data currently available this is unlikely. However in order 
to confirm this a more in-depth analysis than this would require 
further research in latency associated transcripts linked to herpes 
in other animals which is beyond the scope of this study.
Unfortunately the EHV status of the donor horses was unknown. 
The clinical history for one of the TETC donors containing virus 
was available. The donor was presented at the hospital with right 
hind lameness and proprioceptive deficits. The horse was eutha-
nased on humane grounds. EHV myeloencephalopathy was not 
suspected on presentation due to the absence of cauda equina 
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Response
All the RNA samples were used in the studies pertaining to this manuscript.
Reviewer
Did the authors collect these tenocytes from tissue that was known to be septic antemortem? I
wonder if this statement is a jump too far.
Response
All samples were grossly normal on collection. Hospital derived samples showed no signs of
sepsis.
Reviewer
Were any of the RNA seq hits for the latency associated transcript RNA?
Response
Two different types of mapping were undertaken. Firstly a megablast run against the entire nt
database to get taxonomic information, and  secondly a blastx run against a database  created of
all know ERV genes in animals from NCBI. Therefore the’ latency associated transcripts’ (only
appear to be sequences for these in humans in NCBI) would not have been included. We
assessed the two sequences in NCBI that result from a search for 'latency associated transcript
and herpes' and ran a blastx for both samples against these. Neither resulted in any significant hits.
 Thus whilst latency associated transcripts cannot be ruled out with data currently available this is
unlikely. A more in-depth analysis than this would require further research in latency associated
transcripts linked to herpes in other animals and is beyond the scope of this paper.  We have
amended the manuscript accordingly.
Reviewer
The specific PCR for EHV-2 on tendon tissue did not find any viral DNA however can this test
confirm lack of presence of latency associated transcript RNA?
Response
The reviewer is correct in their assumption. We have amended the manuscript. 
 No competing interests were disclosed.Competing Interests:
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   Duncan Hannant
School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK
This is a very well executed study carried out with high level of rigour to define and describe the findings
of EHV-2 in equine tendon cells. There is one important aspect which potentially confounds the
interpretation of the data. The authors refer to the possibilities of some contamination of samples and
tissue culture reagents as a possible source of EHV-2 virus and PCR products in tendon cells and provide
a good argument to discount these. However, one aspect is not fully considered in their justification of this
potentially novel finding. There have been many published papers describing equine gammaherpes
viruses in PBMC and several tissues/organs in both foals and adult horses. EHV-2 is ubiquitous in horses
and virus and viral genes are commonly found. For example, Torfason et al.  described detection of
EHV-2 and EHV-5 in PBMC and a selection of tissues in about 80% of the animals they examined using
co-cultivation methods to demonstrate infectious replicating virus. EHV-2 is common in foals but these
observations were also made in older horses on this occasion. As with other gammaherpes viruses,
EHV-2 is known to be latent in B lymphocytes (Drummer et al. ) and these latent viruses were
re-activated and identified by co-cultivation methods. These and other findings strongly suggest that
EHV-2 virus or cells containing EHV-2 genes would have been present in a high proportion of tissue
samples taken from horses for this study. Many samples were from slaughterhouse materials but even so,
it would have been very difficult to remove tendon tissues from horses without significant contamination
by infected (or latently-infected) cells. 
These possibilities should be discussed fully in the paper. It is possible also that cell-to-cell contact of
infected PBMC or other donor cells with tenocytes is the route of infection of the latter in vivo. This would
be perfectly acceptable as a method by which EHV-2 genes and virus were detected in cultured
tenocytes. The fact that the authors detected virus in only 2 of the 13 samples might also be worthy of
note, considering that this virus is so ubiquitous. 
 Do the authors know if the positive samples were from old or young horses?
The considerations above do not detract from the findings that equine tendon cells may contain EHV-2
and that this might have implications for use of these cells therapeutically to treat tendinopathy. The
contention is that the paper should discuss the findings in relation to published papers such as those
indicated above and the potential likelihood of this finding not being unexpected.
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